Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

• Autor(a) principal: Marques, Vanessa Daccach
• Data de Publicação: 2018
• Outros Autores: Passos, Giordani Rodrigues dos, Mendes, Maria Fernando, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Comini-Frota, Elizabeth Regina, Ferreira Vasconcelos, Claudia Cristina, Sato, Douglas Kazutoshi, Brito Ferreira, Maria Lucia, Fiuza Parolin, Monica Koncke, Damasceno, Alfredo, Grzesiuk, Anderson Kuntz, Muniz, Andre, Cunha Matta, Andre Palma da, Santos de Oliveira, Bianca Etelvina, Taui, Carlos Bernardo, Kaimen Maciel, Damacio Ramon, Diniz, Denise Sisteroli, Correa, Eber Castro, Coronetti, Fernando [UNESP], Jorge, Frederico M. H., Sato, Henry Koiti, Magno Goncalves, Marcus Vinicius, Sousa, Nise Alessandra de C., Noscimento, Osvaldo J. M., Gama, Paulo Diniz da, Domingues, Renan, Simm, Renato Faria, Thomaz, Rodrigo Barbosa, Morales, Rogerio de Rizo, Dias, Ronaldo Maciel, Apostolos-Pereira, Samira dos, Nunes Machado, Suzana Costa, Junqueira, Thiago de Faria, Becker, Jefferson
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1590/0004-282X20180078; http://hdl.handle.net/11449/164827
• topic: multiple sclerosis; drug therapy; consensus

The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In this context, experts from the Brazilian Committee on Treatment and Research in Multiple Sclerosis and the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology have convened to establish this Brazilian Consensus for the Treatment of MS, based on their understanding that neurologists should be able to prescribe MS DMTs according to what is better for each patient, based on up-to-date evidence and practice. We herein propose practical recommendations for the treatment of MS, with the main focus on the choice and management of DMTs, as well as present a review of the scientific rationale supporting therapeutic strategies in MS.